Evidence map›Paper›PMID 26811502›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

MINCR is not a MYC-induced lncRNA.

Jonathan R Hart, Marc S Weinberg, Kevin V Morris, Thomas C Roberts, Kim D Janda, Amanda L Garner, Peter K Vogt

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Reply to Hart et al.: MINCR and MYC: More than expression correlation.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jonathan R HartDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037;
Marc S WeinbergHIV Pathogenesis Research Unit, Department of Molecular Medicine and Haematology, University of the Witwatersrand Medical School, Johannesburg 2193, South Africa;
Kevin V MorrisSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia;
Thomas C RobertsDevelopment, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037;
Kim D JandaDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037;
Amanda L GarnerDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109.
Peter K VogtDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037; pkvogt@scripps.edu.

Funding

Targeted inhibition of HIV-1 latencyR01AI111139 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2014 to 2018
$2.7M
NIAID NIH HHS R01 AI111139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksBurkitt LymphomaHumansLymphoma, B-CellProto-Oncogene Proteins c-mycRNA, Long NoncodingProto-Oncogene Proteins c-mycRNA, Long Noncoding

Identifiers

PMID26811502
PMCPMC4747730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.